Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 17;13(5):e074221.
doi: 10.1136/bmjopen-2023-074221.

Efficacy and safety of carbon dioxide insufflation for brain protection for patients undergoing planned left-sided open heart valve surgery: protocol for a multicentre, placebo-controlled, blinded, randomised controlled trial (the CO2 Study)

Rachel Todd  1 , Chris A Rogers  2 , Maria Pufulete  2 , Lucy Culliford  2 , Pieter Pretorius  3 , Natalie Voets  3 , Enoch Akowuah  4 , Rana Sayeed  5 , Michelle Lazaroo  2 , Surinder Kaur  6 , Gianni D Angelini  7   8 , Ben Gibbison  7   8
Affiliations

Efficacy and safety of carbon dioxide insufflation for brain protection for patients undergoing planned left-sided open heart valve surgery: protocol for a multicentre, placebo-controlled, blinded, randomised controlled trial (the CO2 Study)

Rachel Todd et al. BMJ Open. .

Abstract

Introduction: Brain injury is common following open heart valve surgery. Carbon dioxide insufflation (CDI) has been proposed to reduce the incidence of brain injury by reducing the number of air microemboli entering the bloodstream in surgery. The CO2 Study will evaluate the efficacy and safety of CDI in patients undergoing planned left-sided open heart valve surgery.

Methods and analysis: The CO2 Study is a multicentre, blinded, placebo-controlled, randomised controlled trial. Seven-hundred and four patients aged 50 years and over undergoing planned left-sided heart valve surgery will be recruited to the study, from at least eight UK National Health Service hospitals, and randomised in a 1:1 ratio to receive CDI or medical air insufflation (placebo) in addition to standard de-airing. Insufflation will be delivered at a flow rate of 5 L/min from before the initiation of cardiopulmonary bypass until 10 min after cardiopulmonary bypass weaning. Participants will be followed up until 3 months post-surgery. The primary outcome is acute ischaemic brain injury within 10 days post-surgery based on new brain lesions identified with diffusion-weighted MRI or clinical evidence of permanent brain injury according to the current definition of stroke.

Ethics and dissemination: The study was approved by the East Midlands-Nottingham 2 Research Ethics Committee in June 2020 and the Medicines and Healthcare products Regulatory Agency in May 2020. All participants will provide written informed consent prior to undertaking any study assessments. Consent will be obtained by the principal investigator or a delegated member of the research team who has been trained in the study and undergone Good Clinical Practice training. Results will be disseminated through peer-reviewed publications and presentations at national and international meetings. Study participants will be informed of results through study notifications and patient organisations.

Trial registration number: ISRCTN30671536.

Keywords: cardiac surgery; clinical trial; delirium & cognitive disorders; magnetic resonance imaging; stroke.

PubMed Disclaimer

Conflict of interest statement

Competing interests: CR, GDA and BG received support from the National Institute for Health and Care Research for the project associated with this manuscript, which was paid to the University of Bristol. RT, MP, LC, ML and SK received support from the National Institute for Health and Care Research for the project associated with this manuscript, which contributed to their salary. PP, NV and RS received support from the National Institute for Health and Care Research for the project associated with this manuscript, which was paid to the University of Oxford. EA received support from the National Institute for Health and Care Research for the project associated with this manuscript, which was paid to the RS reports ad hoc payments for providing expert testimony for the Parliamentary & Health Service Ombudsman. RS is the director and shareholder of Oxford Heart Surgery, chairs the Intercollegiate Speciality Board on Cardiothoracic Surgery, and is a member of the Special Advisory Committee in Cardiothoracic Surgery for the Royal Surgery Colleges. RS is an honorary secretary of the Society for Cardiothoracic Surgery in Great Britain and Ireland. No other conflicts were reported.

Figures

Figure 1
Figure 1
Trial schema. ACEIII, Addenbrooke’s Cognitive Examination III; CAM, Confusion Assessment Method; CPB, cardiopulmonary bypass; DW MRI, diffusion-weighted MRI; NIHSS, National Institutes for Health Stroke Scale; oTMT A&B, oral Trail Making Tests part A&B; QoL, Quality of Life; SAE, serious adverse event; SF-12, Short-Form Health Survey Questionnaire.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

  • 2024 EACTS/EACTAIC/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery.
    Wahba A, Kunst G, De Somer F, Agerup Kildahl H, Milne B, Kjellberg G, Bauer A, Beyersdorf F, Berg Ravn H, Debeuckelaere G, Erdoes G, Haumann RG, Gudbjartsson T, Merkle F, Pacini D, Paternoster G, Onorati F, Ranucci M, Ristic N, Vives M, Milojevic M; EACTS/EACTAIC/EBCP Scientific Document Group. Wahba A, et al. Eur J Cardiothorac Surg. 2025 Feb 4;67(2):ezae354. doi: 10.1093/ejcts/ezae354. Eur J Cardiothorac Surg. 2025. PMID: 39949326 Free PMC article. No abstract available.
  • 2024 EACTS/EACTAIC/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery.
    Wahba A, Kunst G, De Somer F, Agerup Kildahl H, Milne B, Kjellberg G, Bauer A, Beyersdorf F, Berg Ravn H, Debeuckelaere G, Erdoes G, Haumann RG, Gudbjartsson T, Merkle F, Pacini D, Paternoster G, Onorati F, Ranucci M, Ristic N, Vives M, Milojevic M; EACTS/EACTAIC/EBCP Scientific Document Group. Wahba A, et al. Interdiscip Cardiovasc Thorac Surg. 2025 Feb 5;40(2):ivaf002. doi: 10.1093/icvts/ivaf002. Interdiscip Cardiovasc Thorac Surg. 2025. PMID: 39949317 Free PMC article. No abstract available.
  • 2024 EACTS/EACTAIC/EBCP Guidelines on cardiopulmonary bypass in adult cardiac surgery.
    Wahba A, Kunst G, De Somer F, Kildahl HA, Milne B, Kjellberg G, Bauer A, Beyersdorf F, Ravn HB, Debeuckelaere G, Erdoes G, Haumann RG, Gudbjartsson T, Merkle F, Pacini D, Paternoster G, Onorati F, Ranucci M, Ristic N, Vives M, Milojevic M; EACTS/EACTAIC/EBCP Scientific Document Group. Wahba A, et al. Br J Anaesth. 2025 Apr;134(4):917-1008. doi: 10.1016/j.bja.2025.01.015. Epub 2025 Feb 14. Br J Anaesth. 2025. PMID: 39955230 Free PMC article.

References

    1. SurgerySfC . National cardiac surgery activity and outcomes report 2002–2016. Soc Cardio Surg 2020.
    1. Cropsey C, Kennedy J, Han J, et al. . Cognitive dysfunction, delirium, and stroke in cardiac surgery patients. Semin Cardiothorac Vasc Anesth 2015;19:309–17. 10.1177/1089253215570062 - DOI - PubMed
    1. Kotfis K, Szylińska A, Listewnik M, et al. . Early delirium after cardiac surgery: an analysis of incidence and risk factors in elderly (≥65 years) and very elderly (≥80 years) patients. Clin Interv Aging 2018;13:1061–70. 10.2147/CIA.S166909 - DOI - PMC - PubMed
    1. Sun X, Lindsay J, Monsein LH, et al. . Silent brain injury after cardiac surgery: a review: cognitive dysfunction and magnetic resonance imaging diffusion-weighted imaging findings. J Am Coll Cardiol 2012;60:791–7. 10.1016/j.jacc.2012.02.079 - DOI - PubMed
    1. Mack MJ, Acker MA, Gelijns AC, et al. . Effect of cerebral embolic protection devices on CNS infarction in surgical aortic valve replacement: a randomized clinical trial. JAMA 2017;318:536–47. 10.1001/jama.2017.9479 - DOI - PMC - PubMed

Publication types

LinkOut - more resources